Introduction
Medulloblastoma is the most common primary brain tumour occurring in children with a male preponderance. In the last few years, whole-genome gene ex pression studies have provided strong molecular evidence supporting the notion that medulloblastomas re present a heterogeneous disease. Molecular subgroups of medulloblastoma have been identified based on the expression profile of specific sets of genes [15, 27] . However, the major biological factors and mechanisms that affect homeostasis and underline pathogenesis of the tumour subtypes remain unclear. Both genetic and epigenetic factors have been shown to influence the host response which may contribute to the growth of tumours.
Tumorigenesis is a multi-step process involving the alteration of a number of key cellular properties in cluding uncontrolled proliferation, vascularisation (angiogenesis) and subsequent invasion and migration of tumour cells into the surrounding tissues [13] . The role of inflammation is especially important. How ever, while the normal inflammatory cascade is self-limiting and crucial for host protection against invading pathogens or in the repair of damaged tissue, a wealth of evidence documents that chronic inflammation is the engine driving carcinogenesis. In the early neoplastic process, inflammatory cells are recognizable tumour promoters, producing an attractive environment for tumour growth, facilitating genomic instability and promoting angiogenesis. Later in the tumorigenic process, neoplastic cells also divert inflammatory mechanisms to favour neoplastic spread and metastasis. The relationship between inflammation, immunity and cancer is widely accepted but mechanisms mediating this relationship remain unknown. Understanding the molecular processes of these cellular phenotypic changes may be critical to develop novel therapies. Central to mediating such changes is the interaction between cell surface receptors and their cognate ligands, which through intracellular signalling induce alterations in gene expression of the cells.
In this context, our present study was undertaken to examine the presence and distribution of Tolllike receptors (TLRs) in necrotic areas of medulloblastoma. These receptors fulfil the criteria postulated for the receptors of innate immunity called pattern-recognition receptors (PRR). Signalling from TLRs in volves transcription factors that are activated and trans-located into the cell nucleus to induce new genes that encode synthesis of various pro-inflammatory cytokines, enzymes and mediators [1, 7, 17, 19, 25, 29] . TLRs recognize highly conserved molecules present in microorganisms but they can also respond to some endogenous pathogens released by the host necro tic tissue. We suspected that medulloblastoma necro tic areas could be a source of unknown tumour pa thogens that could be ligands for TLRs. Therefore, knowledge of TLRs distribution in medulloblastoma may shed some light on the relationship between the tumour and its harmful effect on the surrounding normal nervous tissue.
Material and methods
Medulloblastoma samples containing areas of necrosis within the tumour and/or within the normal nerve tissue at the periphery of the tumour, were selected from the brain paraffin blocks of the patients who died at different ages of life (1-5, 17, 37 years). Paraffin blocks of the tissue were drawn from archives of the Institute of Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland and cut to serial sections 10 µm thick, stained with H&E for routine histological examination and used for immunohistochemical study.
I Im mm mu un no oh hi is st to oc ch he em mi is st tr ry y Immunohistochemistry was performed using the avidin-biotin-peroxidase complex system, according to the manufacturer's recommendations (Vectastain Elite ABC Peroxidase Kit; Vector Laboratories).
Briefly, sections were dewaxed and hydrated through descending alcohols to water. For non-enzymatic antigen retrieval, sections were heated in 0.01 M sodium citrate buffer (pH 6.0) to 95°C and allowed to cool for 20 min at room temperature and washed with PBS. Then, sections were incubated in methanol/3% H 2 O 2 solution for 20 min to quench endogenous peroxidase. Washed again in PBS and blocked with a solution containing PBS/5% normal serum of goat, rabbit or mouse for 2 h at room temperature, sections were incubated overnight at 4°C in solutions of primary antibodies listed in Table I .
Immunoreactions were visualized using biotinylated secondary antibodies and ABComplex/HRP or an alkaline phosphatase-avidin-biotin conjugate. Then, sections were lightly counterstained with Mayer's haematoxylin. Numbers of immunopositive cells were counted in each of five serial sections under light microscope (magnification ×200) as previously described [17, 25] .
For negative controls, primary antibodies were replaced with an appropriate isotypic normal mouse, rabbit or goat immunoglobulin fraction at matched protein concentration. These were included for the exami nation of each specimen and consistently produced negative results.
Results
Histologically, all medulloblastoma tumours were composed of sheets or lobules of small cells with prominent nuclei and little cytoplasm. Two types of necrotic areas were stated.
In the first type, the area of dead cells was surrounded by undifferentiated medulloblastoma cells. The nuclei of these cells were compact, dark, round oval to somewhat elongated, or larger and more vesicular with distinct chromatin clumps. A lot of these cells expressed TLR 2 (Fig. 1A, B) and TLR 3 antigens (Fig. 1C) . TLR 2 was also strongly and precisely expressed in the walls of dense network of capillaries that fulfil tumour regions Toll-like receptors in medulloblastoma already cleared from dead cells (Fig. 2) . In addition, some regions of solid tumour were patrolled by single TLR2 immuno-positive cells that were scattered throughout the neoplastic tissue (Table II 
Discussion
Inflammatory reaction is commonly associated with many types of neoplasms. Most tumours have antigenic qualities that are recognized by T cells to provoke an immune response, which would be expected to eliminate or retard the tumour cells; by contrast, immunosuppression should increase the incidence of cancer [5] . A variety of clinical and experimental data seem to be in agreement with this theory of immune surveillance.
Results of our present study document that Tolllike receptors as receptors of innate immunity may play an important role in immune mechanisms of patients with medulloblastoma. We found that TLR 2 and TLR 3 were clearly associated with necrotic areas of medulloblastoma. Both receptors were precisely distributed on tumour cells around necrosis suggesting that in these undifferentiated cells, an innate immune system is present and can recognize pathogens delivered by dying cells. The nature of the pathogens remains unknown but it was previously documented that TLR 2 can bind pathogens such as lipoproteins/lipopeptides [3] , peptidoglycan [23, 26] , lipoteichoic acid [23] , lipoarabinomannan [20] , phenol-soluble modulin [12] , glycoinositolphospholipids [8] , glycolipids [21] , porins [18] , atypical lipopolysaccharides [14, 31] , zymosan [28] , all of them found in different microorganisms.
TLR 2 may bind also proteins delivered by necrotic host tissue [4] .
In the presented study, a strong immunoexpression of TLR 2 on the wall of de novo formed blood vessels in medulloblastoma was found and suggests that TLR 2 plays an important role in tumour angiogenesis. Previously, the participation of TLR2 in neovascularization was observed during inflammation and wound healing process. Moreover, it has been documented that TLR 2 participated in such neovascularization after binding the end products of lipid oxidation that were accumulated at high levels during inflammation [32] . Thus, in our study, pathogens delivered by dying tumour cells of medulloblastoma may be similar in nature to those end products detected in inflammation.
Ligands for TLR 3 are less known than ligands for TLR 2 but they were characterized as double-stranded RNA molecules and the synthetic analogue polyino -F Fi ig g. . 2 2. . TLR 2 strongly and precisely immunoexpressed on walls of blood vessels that fulfil tumour areas already cleared from dead cells; original magnification ×100. 
O -lack of antigen in tissue sections; + -< 10%; ++ -25-40%; +++ -40-60%; ++++ -60-80% of tumour cells (or nerve tissue cells). Numbers of immunopositive cells were counted in each of five serial sections under light microscope (magnification ×200
). In addition, immunohistochemical staining was graded for strength: 1 -weak reaction; 2 -strong reaction. Both strength and distribution estimation methods were previously described [17, 25] Toll-like receptors in medulloblastoma sinic-polycytidylic acid, a viral RNA mimetic, has been shown to be a TLR3 agonist [2] . Results of our study suggest also that the activated innate immune system of tumour cells may initiate inflammatory response in the nervous tissue surrounding the tumour. It would be expected that the recognition of tumour pathogens by the receptors of the innate immune system will lead to an inflammatory response resulting in disruption of nervous tissue homeostasis at the tumour periphery.
Although the innate immune system has been regarded as a relatively nonspecific immunity, it is capable of differentiating between self and non-self. The innate immunity is present in the organism since birth, not requiring repeated exposure to pathogens, although it has a broad spectrum of resistance to infections and pathogens of tissue injury. Moreover, the innate immunity controls the adaptive immune system, which, in turn, has been developed by mammals as a more specific and complex but complementary defence system. The central nervous system (CNS), considered as an immunologically privileged organ, has well-organized innate immunity. The constitutively expressed TLRs were found in the regions devoid of the blood-brain barrier as circumventricular organs and in choroid plexus or leptomeninges. These receptors respond immediately to microbial pathogens circulating in the systemic infections or to endogenous pathogens released by necrotic tissue after trauma, transplantation or burns. Results of the present study show that such pathogens may be also produced by dead medulloblastoma cells. The role of TLRs in pathology of the CNS was a subject of numerous studies, which documented the implication of TLR 2 signalling in glia responses associated with repair by the clearance of myelin debris [6, 9, 10] .
The TLR 2 ligand peptidoglycan was detected in phagocytes functioning within multiple sclerosis le sions [22] . Administration of the TLR 2 ligand zymosan promoted regeneration after optic nerve crush injury [16] , and systemic injection of the TLR 4 ligand -LPS accelerated myelin clearance in the injured spinal cord [30] . Direct injection of TLR ligands into the healthy brain or spinal cord induced robust inflammation that caused tissue damage [11, 24] .
In our patients the role of TLR 2-immunopositive cells, scattered throughout the solid tumour region of medulloblastoma is not known but they seem to patrol the tumour looking for ligands similar to those re leased by tumour necrotic areas. On the other hand, circulating pathogens may also activate endothelial and perivascular cells that produce soluble molecules into the brain parenchyma. These TLRs recognize the foreign invaders and during signalling transcription factors (nuclear factor-kB or interferon regulatory factor 3) are translocated into the cell nucleus to induce new genes that encode synthesis of various pro-inflammatory cytokines, enzymes and mediators [7, 29] . The regulation of inflammation occurs on many levels, but the initial events are triggered upon TLR pathogen recognition. Since the 
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pro inflammatory molecules, when released in excess, may induce serious systemic disorders, organisms have evolved mechanisms for modulating their TLR-mediated responses [1] . The expression of TLR network in the CNS is dynamically regulated but may vary significantly in patients with neoplasm, depending on the state of the disease or effects of the treatment. Evidence now suggests that both innate and adaptive immune responses may initiate inflammation of the CNS. The spectrum of CNS diseases have syndromes of inflammatory and immune components. However, the direction that inflammation is taking may consequently be crucial for determining the ultimate outcome of insults in CNS. Recently, rapid progress has been made in our understanding of the molecular mechanisms of innate immunity; TLRs are suggested as potential therapeutic targets in the injured or diseased CNS.
The knowledge of the ligands, receptors and signalling pathways of innate immune responses during infections, inflammation and tumourigenesis provides new approaches for selective therapeutics.
Our findings show a new function of TLRs as sensors of pathogens released by medulloblastoma dead cells. This new function may provide a key link connecting innate immunity, neuroinflammation and angiogenesis in the tumour.
